41 results

• Whistleblower Lawsuit Over Suboxone Kickback Scheme Allowed to Proceed by Judge

  October 27, 2023

  Irvin Jackson

  A federal judge has cleared the way for a Suboxone whistleblower lawsuit to proceed, claiming the manufacturers engaged in a kickback scheme which led to Medicare paying more for the opioid addiction drug than necessary.

• Bayer Whistleblower Settlement Over Trasylol, Avelox and Baycol Results in $40 Million Payment

  September 7, 2022

  Irvin Jackson

  Bayer has agreed to pay $40 million to resolve a whistleblower lawsuit which accused it of kickback schemes and off-label marketing of the drugs Avelox, Baycol and Trasylol.

• Acthar Settlement Results in $260M Payment to Resolve DOJ Fraud and Illegal Kickback Allegations

  March 9, 2022

  Irvin Jackson

  Mallinckrodt will pay $260 million to resolve illegal Medicaid fraud and kickback claims brought against it by whistleblowers and the federal government over its marketing of Acthar gel.

• SEC Whistleblower Settlements Have Resulted in $1 Billion in Awards Paid For Uncovering Violations of Securities Laws

  September 20, 2021

  Russell Maas

  Whistleblower claims hit a $1 billion landmark this month in money rewarded to those who uncover fraud against the government.

• Whistleblower Lawsuit Over AstraZeneca Off-Label Marketing Ends in $2.4M Verdict

  June 24, 2021

  Irvin Jackson

  An Oregon jury wants AstraZeneca to pay $2.4 million for violating a former employee's whistleblower rights after she claimed the company was illegally marketing the asthma drug Symbicort.

• Whistleblower Lawsuits May Have Helped Reduce Fraudulent Heart Stent Surgeries: Study

  September 23, 2020

  Irvin Jackson

  A new study finds that whistleblower lawsuits against doctors who performed unnecessary heart stenting procedures may have helped clamp down on cases of medical fraud.

• DOJ Recovered More Than $2.8 Billion Under False Claims, Whistleblower Acts In 2018

  January 16, 2019

  Russell Maas

  The Justice Department says it recovered nearly $3 billion in fraud claims last year, mostly from healthcare fraud, thanks in large part to whistleblowers.

• Illegal Marketing of Relieva Stratus MicroFlow Spacer Results in $18M Settlement by J&J Unit

  July 27, 2016

  Russell Maas

  A whistleblower lawsuit has resulted in Johnson & Johnson subsidiary Acclarent paying $18 million to settle federal claims that it illegally marketed a drug delivery system without FDA approval.

• Nexium Settlement For Illegal Marketing Scheme Results in $7.9M AstraZeneca Payment

  February 12, 2015

  Staff Writers

  The DOJ has accused AstraZeneca of giving kickbacks to a pharmacy benefit manager to push its drug Nexium, resulting ina $7.9 million whistleblower lawsuit settlement.

• Medtronic SubQ Stimulation Settlement Results False Claims Allegations for $2.8M

  February 11, 2015

  Irvin Jackson

  The DOJ has announced a $2.8 million settlement with Medtronic over the alleged illegal promotion of the use of some of its devices for unapproved pain treatments.